RELMADA THERAPEUTICS, INC.: 10-Q filed 2015-05-15
What RELMADA THERAPEUTICS, INC. reported in its quarterly report filed 2015-05-15 (fiscal Q3 2015): 27 published measures, 75 facts as tagged in accession 0001213900-15-003882.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-05-15
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001213900-15-003882 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All RELMADA THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 27,849,811 | USD | |
| At 2014-06-30 | 25,764,450 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 25,355,851 | USD | |
| At 2014-06-30 | 26,873,411 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 2,493,960 | USD | |
| At 2014-06-30 | -1,108,961 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 26,956,404 | USD | |
| At 2014-06-30 | 25,564,351 | USD | |
| At 2014-03-31 | 2,459,132 | USD | |
| At 2013-12-31 | 3,522,450 | USD | |
| At 2013-06-30 | 1,559,728 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | -2,462,961 | USD | 90 |
| 2014-07-01 to 2015-03-31 | -26,846,032 | USD | 274 |
| 2014-01-01 to 2014-03-31 | 6,493,830 | USD | 90 |
| 2013-07-01 to 2014-03-31 | -238,206 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-03-31 | -11,737,904 | USD | 274 |
| 2013-07-01 to 2014-03-31 | -1,846,500 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-03-31 | 13,149,413 | USD | 274 |
| 2013-07-01 to 2014-03-31 | 2,755,374 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-03-31 | -19,456 | USD | 274 |
| 2013-07-01 to 2014-03-31 | -9,470 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | -82,164,676 | USD | |
| At 2014-06-30 | -55,318,647 | USD |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | -0.05 | USD/shares | 90 |
| 2014-07-01 to 2015-03-31 | -0.56 | USD/shares | 274 |
| 2014-01-01 to 2014-03-31 | 1.98 | USD/shares | 90 |
| 2013-07-01 to 2014-03-31 | -0.1 | USD/shares | 274 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | -0.05 | USD/shares | 90 |
| 2014-07-01 to 2015-03-31 | -0.56 | USD/shares | 274 |
| 2014-01-01 to 2014-03-31 | 0.42 | USD/shares | 90 |
| 2013-07-01 to 2014-03-31 | -0.1 | USD/shares | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 23,348 | USD | |
| At 2014-06-30 | 9,841 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-03-31 | 600,076 | USD | 274 |
| 2013-07-01 to 2014-03-31 | 447,780 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | -4,567,829 | USD | 90 |
| 2014-07-01 to 2015-03-31 | -12,675,288 | USD | 274 |
| 2014-01-01 to 2014-03-31 | -711,896 | USD | 90 |
| 2013-07-01 to 2014-03-31 | -6,248,919 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 27,814,363 | USD | |
| At 2014-06-30 | 25,742,509 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | 125 | USD | 90 |
| 2014-07-01 to 2015-03-31 | 4,491 | USD | 274 |
| 2014-01-01 to 2014-03-31 | 123,800 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 302,440 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 25,255,851 | USD | |
| At 2014-06-30 | 26,773,411 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 390,371 | USD | |
| At 2014-06-30 | 746,098 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | -4,567,829 | USD | 90 |
| 2014-07-01 to 2015-03-31 | -12,675,288 | USD | 274 |
| 2014-01-01 to 2014-03-31 | -711,896 | USD | 90 |
| 2013-07-01 to 2014-03-31 | -6,248,919 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | -2,274,767 | USD | 90 |
| 2014-07-01 to 2015-03-31 | -5,007,669 | USD | 274 |
| 2014-01-01 to 2014-03-31 | -215,793 | USD | 90 |
| 2013-07-01 to 2014-03-31 | -4,755,911 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 53,735,211 | shares | |
| At 2014-06-30 | 40,294,217 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 84,604,436 | USD | |
| At 2014-06-30 | 54,166,055 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-03-31 | 398,485 | USD | |
| At 2014-06-30 | 382,023 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | -2,293,062 | USD | 90 |
| 2014-07-01 to 2015-03-31 | -7,667,619 | USD | 274 |
| 2014-01-01 to 2014-03-31 | -496,103 | USD | 90 |
| 2013-07-01 to 2014-03-31 | -1,493,008 | USD | 274 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-03-31 | 5,949 | USD | 274 |
| 2013-07-01 to 2014-03-31 | 373 | USD | 274 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-03-31 | 2,104,868 | USD | 90 |
| 2014-07-01 to 2015-03-31 | -14,170,744 | USD | 274 |
| 2014-01-01 to 2014-03-31 | 7,205,726 | USD | 90 |
| 2013-07-01 to 2014-03-31 | 6,010,713 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2015-03-31 | -355,727 | USD | 274 |
| 2013-07-01 to 2014-03-31 | 24,975 | USD | 274 |
Inspect the source
- Entity
- RELMADA THERAPEUTICS, INC. / CIK 0001553643
- Captured
- SEC response SHA-256
34acb6579adb694402af1f940d83014f7841c8cf763b03e27ee64d386466bb53
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001553643.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))